SVEGLIATI BARONI, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 5.969
EU - Europa 2.589
AS - Asia 496
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 3
OC - Oceania 2
SA - Sud America 2
Totale 9.067
Nazione #
US - Stati Uniti d'America 5.941
UA - Ucraina 606
IT - Italia 446
IE - Irlanda 399
SE - Svezia 375
DE - Germania 258
DK - Danimarca 199
TR - Turchia 142
SG - Singapore 137
GB - Regno Unito 131
FI - Finlandia 104
KR - Corea 96
CN - Cina 89
CA - Canada 28
FR - Francia 20
IN - India 20
PL - Polonia 16
BE - Belgio 15
EU - Europa 6
AT - Austria 4
EG - Egitto 3
JP - Giappone 3
NL - Olanda 3
RO - Romania 3
RS - Serbia 3
RU - Federazione Russa 3
VN - Vietnam 3
AU - Australia 2
IR - Iran 2
PK - Pakistan 2
TW - Taiwan 2
CH - Svizzera 1
EC - Ecuador 1
HR - Croazia 1
LU - Lussemburgo 1
PE - Perù 1
PT - Portogallo 1
Totale 9.067
Città #
Chandler 778
Jacksonville 651
Fairfield 593
Des Moines 459
Ashburn 396
Dublin 396
Wilmington 283
Woodbridge 268
Houston 243
Seattle 204
Boardman 191
Cambridge 190
New York 180
Centro 172
Lawrence 152
Princeton 152
San Mateo 144
Ann Arbor 142
San Diego 88
Turin 48
Guangzhou 43
Beijing 36
Los Angeles 34
London 33
Washington 32
Ottawa 24
Norwalk 21
Pune 20
Redmond 20
Brussels 15
Marche 15
Kraków 13
Milan 11
Kilburn 10
Izmir 9
Porto 9
Chiswick 8
Helsinki 8
Rome 7
Ancona 6
Appignano 6
Civitanova Marche 6
Hounslow 6
Nanjing 6
Southwark 6
Casoria 5
Falls Church 5
New Bedfont 5
Pescara 5
Torre Annunziata 5
Dearborn 4
Lunano 4
Napoli 4
Prescot 4
Senigallia 4
Vienna 4
Acton 3
Belgrade 3
Bologna 3
Falerone 3
Hanover 3
Ho Chi Minh City 3
Toronto 3
Andover 2
Bristol 2
Cairo 2
Chicago 2
Edinburgh 2
Fayetteville 2
Imola 2
Islington 2
Kyiv 2
Nanning 2
Padova 2
Redwood City 2
San Benedetto del Tronto 2
Slobozia 2
Taipei 2
Venice 2
Wandsworth 2
Abbiategrasso 1
Acquaviva Picena 1
Agrigento 1
Ascoli Piceno 1
Bari 1
Baricella 1
Brisbane 1
Changsha 1
Coimbra 1
Dallas 1
Falkenstein 1
Falkirk 1
Fermo 1
Fiano 1
Florence 1
Islamabad 1
Izhevsk 1
Kagoya 1
Lanciano 1
Lima 1
Totale 6.258
Nome #
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 136
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 110
Acetaldehyde-collagen adducts in N-nitrosodimethylamine-induced liver cirrhosis in rats. 97
Hepatitis E in a region of Italy: An emerging autochthonous infection? 95
Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals 93
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 93
Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. 88
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 88
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 87
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 86
From the metabolic syndrome to NAFLD or vice versa? 85
Mechanisms for increased risk of diabetes in chronic liver diseases 85
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 84
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 84
Plasma membrane order parameter in periportal and perivenular hepatocytes isolated from ethanol-treated rats. 83
Collagen synthesis by liver stellate cells is released from its normal feedback regulation by acetaldehyde-induced modification of the carboxyl-terminal propeptide of procollagen. 82
Collagen-acetaldehyde adducts in alcoholic and nonalcoholic liver diseases. 82
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 80
The Na+/H+ exchanger modulates the fibrogenic effect of oxidative stress in rat hepatic stellate cells. 79
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 79
Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. 77
Fibrogenic effect of oxidative stress on rat hepatic stellate cells. 77
Immunological risk factors in biliary strictures after liver transplantation 77
Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splachnic or Cerebral Venous Thrombosis 77
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 76
Transforming growth factor beta 1 increases the number of apoptotic bodies and decreases intracellular pH in isolated periportal and perivenular rat hepatocytes. 75
Wine: risk factors for liver disease and antifibrotic compounds. 75
Mild impact of SARS-CoV-2 infection on the entire population of liver transplant recipients: the experience of an Italian Centre based in a high-risk area 75
Simultaneous characterization of progenitor cell compartments in adult human liver. 74
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 74
HIV protein gp120 and chemokines receptor for liver fibrosis. 73
Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. 73
Leptin enhances cholangiocarcinoma cell growth. 73
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 73
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 73
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 73
Tocilizumab in COVID-19 interstitial pneumonia 73
Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. 72
Liver transplantation in patients with common variable immunodeficiency: a report of two cases 72
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 72
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 71
Observer agreement in endoscopic assessment of ulcerative colitis. 70
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. 69
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 69
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights. 69
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 69
Glucagon-like peptide-1receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced bya high-fat diet in nonalcoholic steatohepatitis 68
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with nonalcoholic fatty liver disease 68
Predictors of Worse Prognosis in Young and Middle-Aged Adults Hospitalized with COVID-19 Pneumonia: A Multi-Center Italian Study (COVID-UNDER50) 68
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study 67
Increased liver localization of lipopolysaccharides in human and experimental non-alcoholic fatty liver disease 66
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) 66
Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. 65
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 65
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma 65
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 64
Years of life that could be saved from prevention of hepatocellular carcinoma 64
Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients 64
Regulation of intracellular pH in isolated periportal and perivenular rat hepatocytes. 63
Liver transplantation in neurological Wilson's Disease: is there indication? A case report 63
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease 63
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo. 63
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 63
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation 62
Metabolic disorders across hepatocellular carcinoma in Italy 62
Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study. 62
Brivanib in combination with Notch3 silencing shows potent activity in tumour models 61
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression from NAFLD to NASH 61
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 60
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 60
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients. 60
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 60
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 60
Characterization of ion transport mechanisms regulating intracellular pH in hepatic stellate cells. 59
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 59
Fibrogenesis in nonalcoholic steatohepatitis. 58
A 360-degree overview of paediatric NAFLD: Recent insights 58
Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome. 58
Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells. 58
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 58
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 58
Endogenous opioid peptides and chronic liver disease: from bedside to bench. 57
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis 57
Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E) 57
Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. 57
[L-sulpiride versus metoclopramide in functional dyspepsia: a randomized double-blind study] 56
Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. 56
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis. 56
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 56
Lipotoxicity and the gut-liver axis in NASH pathogenesis 56
Therapy with direct-acting antiviral agents in transplanted patients with HCV recurrence: a retrospective analysis 56
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 55
Effect of cyanidin 3-O-β-glucopyranoside on hepatic stellate cell proliferation and collagen synthesis induced by oxidative stress 55
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 55
Correction to: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma (The American Journal of Gastroenterology, (2016), 111, 1, (70-77), 10.1038/ajg.2015.389) 55
BILE ACIDS INDUCE HEPATIC STELLATE CELL PROLIFERATION VIA ACTIVATION OF THE EPIDERMAL GROWTH FACTOR 54
Gut-pancreas-liver axis as a target for treatment of nafld/nash 54
Liver carcinogenesis: Rodent models of hepatocarcinoma and cholangiocarcinoma 53
Chronic ethanol feeding increases apoptosis and cell proliferation in rat liver. 53
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 53
Totale 6.927
Categoria #
all - tutte 52.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 6 13
2019/2020804 3 2 116 6 125 7 127 1 138 23 58 198
2020/20212.281 147 219 276 52 258 143 207 163 198 225 258 135
2021/20221.316 81 330 39 31 8 52 84 80 80 95 196 240
2022/20232.538 199 257 164 187 154 645 0 132 541 14 177 68
2023/20241.282 239 37 93 272 216 289 23 55 10 44 4 0
Totale 9.357